Download presentation
Presentation is loading. Please wait.
Published byAshley Wright Modified over 9 years ago
1
Mohamed Abdelzaher
2
When is Perimetry Called For? most conclusive and concrete means of establishing a diagnosis of chronic open- angle glaucoma great value in diagnosing neurological diseases but When it comes to managing neurological disease, field testing is not as crucial a technique as it is in glaucoma management; neuroimaging can often replace perimetry. direct observation of the fundus through ophthalmoscopy is usually of greater value in retinal diagnosis GLAUCOMA NEUROLOGICAL DISEASES RETINAL DISEASES
4
Choosing a Test 1) Central vs Peripheral test 2) Stimulus size 3) Test strategy 4) Follow-up test 5) Testing for special conditions
5
Central vs Peripheral testing -Central 30-2 or 24-2 -Central 30-2 or 24-2, Exception : small central scotoma is suspected in a patient who has normal or near-normal visual acuity but a history that suggests acute optic neuritis - central 10-2 -Peripheral e.g. to rule out retinal detachments, or to differentiate between detachment and retinoschisis in eyes that cannot be well visualized ophthalmoscopically GLAUCOMA NEUROLOGICAL DISEASES RETINAL DISEASES
6
Stimulus size Standard size is Goldmann size III Small enough (0.43 degrees in diameter) to be used even in fairly detailed examinations, and large enough to be visible when the patient’s refractive correction is not quite perfect The typical blind spot is roughly 5 by 7 degrees. About two hundred size III stimuli or 12 size V stimuli fit inside the area of a typical blind spot.
7
Advanced glaucoma: use size V stimulus which is 4 times size III stimulus, WHY? Testing with size V stimuli will result in sensitivity levels that are 5 to 10 decibels higher than those found using size III, often extending the available sensitivity range and making it possible to follow such patients. NB. When the size V stimulus is used, one no longer has access to several of the analytical follow-up tools available for the standard size III tests Exception
8
30-2 test using a size III stimulus does not contain enough data for good follow-up Same patient tested with size V stimulus and to the 10-2 pattern resulted in enough data for meaningful long term follow-up
9
Test strategy More diagnostic in glaucoma testing SITA Thresholding: standard - fast Threshold Screening in glaucoma Not sensitive to early glaucomatous changes Sensitive to neurologically based field loss Suprathreshold
10
Switching from the older Full Threshold strategy to SITA Standard cuts test time almost in half for glaucoma patients. Modern threshold perimetry can be very time efficient. Normal subjects can be tested in about 4 minutes; glaucoma patients will take somewhat longer. The SITA strategies have clear advantages over the older strategies and should be used whenever available
11
Follow-up test SITA Standard or SITA Fast 30-2 or 24-2 programs for both glaucoma detection and follow-up The standard test Exceptions * central vision loss: e.g. macular degeneration Patient fixates in the center of a large diamond pattern * very late stages of glaucoma: SITA Standard or SITA Fast 10-2 test use larger stimulus,size V (not with SITA) - Changing test programs in follow-up also makes comparisons with earlier tests more difficult and less exact. - When switching from the earlier standard Humphrey threshold tests, Full Threshold, to the corresponding newer, faster SITA Standard or SITA Fast, the most relevant comparisons can be made by focussing on probability plots.
12
Testing for special conditions Goal: rule out profound visual dysfunction Use: stimulus Goldmann III 4e (10dB) suprathreshold testing Disability Driving Blepharoptosis Drug induced maculopathies e.g. chloroquine, hydroxychloroquine 10-2 test pattern, standard size III white stimulus, SITA standard or SITA fast
13
When perimetric test is needed using a size III white stimulus is the best choice in most cases 30-2 SITA Standard threshold test 24-2 SITA Standard threshold test OR
15
RNFL & ONH Anatomy Arcuate path of axons Superior & Inferior temporal axons do not mix, respect the horizontal raphe Retinotopic organization of axons in optic disc
16
1) Generalized depression: - Can be an early sign of glaucoma - Non specific, also occurs with aging, miosis, or hazy media -Generalized depression can increase the physician’s suspicion that glaucomatous damage has occurred, especially if it is: … unilateral or …. more pronounced in the eye with the higher pressure or larger cup/disc ratio - If the patient has generalized field loss, the MD has a negative sign Common glaucomatous field defects and their anatomical correlates Mild: MD < -6 dB Moderate: MD < -12 dB Severe: MD > -12 dB
17
2) Irregularity of the visual field: - lack of uniformity in the visual field - variation of decibel level among contiguous points that is greater than that anticipated in normal patients of the same age - These areas of loss appear non-uniformly throughout the field - This variation is expressed statistically as the standard deviation of the deviations found in the, Humphrey uses the term pattern standard deviation(PSD),
18
3) Nasal step: Limited field loss adjacent to the nasal horizontal meridian with at least one abnormal point (p < 5%) at or outside 15 degrees on the meridian. Cannot include more than two significant points (on either plot) in the nerve fiber bundle region on the temporal side Anatomy: widespread involvement of fibers in the optic disc will seldom be entirely symmetrical, but usually will involve a larger percentage of lost fibers in either the inferior or superior half of the optic disc. As a result, differential light sensitivity in the opposite visual field halves will not be the same Occurs early in glaucoma and may persist to last stages of the disease
19
4) Isolated Paracentral scotomata: A relatively small visual field abnormality (a cluster or a single point) in the nerve fiber bundle region that is generally not contiguous with the blind spot or the nasal meridian. In particular, it does not involve points outside 15 degrees that are adjacent to the nasal meridian. NB: Scotomata smaller than 6° may be missed in 30-2 field. This is particularly critical in the paracentral region where even very small scotomata can be visually symptomatic. Spacing the test spots closer than 6° (for example 3° apart) increases the chances of identifying such scotomata but also increases the test time to an impractical level. If one is concerned about identifying or monitoring a paracentral scotoma, use the central 10-2 test. notch is partial, that is, it involves only a portion of the axons in the affected area of the optic disc
20
5) Arcuate defect (Bjerrum scotoma) begins at the blind spot, arcs around point of fixation, in the nerve fiber bundle region, end abruptly in at least one point outside 15 degrees adjacent to the nasal horizontal meridian (corresponding to temporal raphe) Anatomy: focal notch in ONH reaching the edge of the disc NB: double arcuate defect Represents middle to late stage glaucoma
21
6) Temporal step: A small visual field defect that is temporal to the blind spot may develop as an isolated finding or in conjunction with other glaucomatous defects more commonly found as a component of late-stage disease Anatomy: erosion of the nasal aspect of the optic disc
22
7) Enlargement of the blind spot: Nonspecific changes for glaucoma If the blind spot enlarges in an arcuate manner, it is called a Seidel’s scotoma and may be seen in early glaucoma
23
8) End stage defects (central and temporal islands): small central island and a larger temporal crescent remaining Anatomy: most of the axons at the superior and inferior poles of the disc are destroyed, leaving only the papillomacular bundle and some nasal fibers
24
Reversal of visual field defects Fluctuation Increasing familiarity with the test Patients following therapy for glaucoma
25
The narrower normal limits of SITA mean that statistically and clinically significant defects can be identified in probability plots even before they are clearly visible in grayscale representations. This happens regularly in patients who are developing early glaucomatous visual field loss, and it is therefore important to focus on probability plots rather than grayscale representations. Pitfalls
26
A large percentage of glaucoma patients have coexisting media opacities, complicating follow-up analysis of their visual fields. These problems can be largely avoided by using analyses based on pattern deviation.
27
Large, sudden visual field changes are not typical in glaucoma. Such changes often occur for reasons other than progression of the glaucomatous disease process, e.g., arterial or venous occlusions in the retina or neurological disease. If a large change is seen and part of the field loss seems hemianopic or occurs in the other eye as well, neurological causes are generally the rule. Glaucomatous field defects may not correspond well to the amount of cupping of the nerve head. During the acute phase of angle-closure glaucoma in patients with high IOP, corneal edema and retinal ischemia can produce bizarre field defects that have little clinical value for following disease progression. After the pressure has been normalized, field defects may remain and may sometimes be extensive if ischemic atrophy of the nerve has occurred. In such cases, pallor of the nerve may be more severe than cupping.
28
Visual field artifacts: 1) Perimetric learning: a large minority, probably 10% to 20%, of patients with a normal visual field do not produce an entirely normal test result on their first test Typically, such fields show depression of sensitivity in the mid-peripheral area 20 to 30 degrees from fixation, while the very central field is normal How to avoid? -Use shorter SITA test -Use 24-2 test point pattern -Do not rely entirely on the 1 st test result, repeat
29
2) Eyelid artifacts: patients with somewhat droopy eyelids will often produce grayscale results that look relatively dark superiorly this type of pattern is common and normal is obvious from the probability plots, where it usually does not result in readings indicating high statistical significance
30
3) Correction lens artifacts: Strong positive correction lenses --- concentrically contracted field Misaligned lenses or their rims may create artifactual patterns
31
4) The cloverleaf field: - very characteristic artifactual pattern -threshold values are normal or near normal at and sometimes around the four primary points where the test begins in all Humphrey threshold programs, but they are much reduced at other locations where the threshold is measured later in the test -occurs when the patient has responded more or less appropriately during the first part of the test, and then given up You have to instruct and supervise patients
32
5) The “Trigger-Happy” field: The patient presses the response button as often as possible, resulting in large numbers of false responses given when, in fact, the patient has not seen the stimulus. This will push up measured threshold values at some points to levels that no human can see. The result is a classical “trigger- happy”field, characterized by patches of abnormally light or even entirely white tones in the grayscale presentation. -High false +ve -GHT: “Abnormally High Sensitivity”
33
Other diseases may cause arcuate nerve fiber bundle visual field defects that may be confused with glaucomatous damage: 1) Chorioretinitis 2) Myopic retinal degeneration 3) Refractive scotomata 4) Trauma 5) Retinal laser damage 6) Optic nerve ischemia 7) Optic nerve compressive lesions 8) Optic neuritis 9) Drusen of optic nerve head
36
In the era of CT and MRI, perimetry remains simple and cost-effective method of making neurological diagnoses because the visual system occupies or passes through so much of the brain. SITA Standard has been found to be at least as good as the older Full Threshold test in detecting optic neuropathies and hemianopias.
37
Optic nerve diseases Central scotoma Altitudinal defect Enlargement of blind spot Optic neuritis: e.g. Toxic, Compressive AION Optic disc swelling Arcuate defect Drusen, Ischemia Centrocecal scotoma
38
Optic chiasm lesions - e.g. pituitary adenomas, craniopharyngiomas, suprasellar meningiomas, aneurysms coming from the arterial circle of Willis
39
Pituitary adenoma craniopharyngioma Bitemporal hemianopia
40
Post chiasmal lesions -Respect the vertical meridian -More posterior More congrouos “extent, pattern” - Extensive defect: Homonymous hemianopia Congrouos hemianopia Incongrouos hemianopia
41
LGB lesion: Homonymous Sectoranopia Homonymous Quadrable sectoranopia
42
Optic radiation and visual cortex lesion:
43
Visual pathways: correlation of lesion site and field defect
44
various causes of visual loss according to lesion site within the afferent visual pathway
46
Most retinal lesions are visible on ophthalmoscopy Importance of field: -field defects found accidentally -to determine whether encountered field loss is caused by one disease or the other e.g. in glaucoma follow-up
47
ARMD central scotoma More evident with 10-2 test Patient tested with the large diamond fixation target
48
CSR central scotoma VA is moderately reduced Resulting field loss may be discrete and visible only on probability plots
49
Retinochoroiditis arcuate or wedge-like defects (DD, glaucomatous field defect) Field defects: -deep and have sharp borders -show much less variability from test to test than glaucomatous lesions
50
Diabetic retinopathy relative and multifocal “mottled” defects Visible in moderate and more advanced stages
51
RD and retinoschises usually located in the peripheral field RD: relative defects, Retinoschises: absolute defects
52
Retinitis pigmentosa Typical field loss is circular and initially located in the midperiphery, progress to tunnel vision Suprathreshold test that includes the peripheral field is preferable, because field defects are often deep and easily identified
53
Retinal vascular occlusions Important when following patients with glaucoma Arterial occlusions typically result in absolute field defects Venous occlusions produce highly variable field loss
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.